Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $56.00 Price Target at Oppenheimer
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its target price reduced by Oppenheimer from $60.00 to $56.00 in a research report released on Wednesday,Benzinga reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. CRBP has been the topic of several other reports. Jefferies Financial Group lowered their price target on shares of […]
More Stories
PVH Corp. (NYSE:PVH) Shares Sold by Public Employees Retirement System of Ohio
Public Employees Retirement System of Ohio lowered its stake in PVH Corp. (NYSE:PVH – Free Report) by 6.3% in the...
Promising Streaming Stocks To Follow Today – May 31st
NVIDIA, AppLovin, Spotify Technology, Walt Disney, Comcast, Live Nation Entertainment, and Take-Two Interactive Software are the seven Streaming stocks to...
Large Cap Stocks To Follow Today – May 31st
NVIDIA, Tesla, and Invesco QQQ are the three Large Cap stocks to watch today, according to MarketBeat’s stock screener tool....
Top Automotive Stocks To Watch Now – May 30th
NVIDIA, Tesla, and Costco Wholesale are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive...
Man Throws Firebombs at Pro-Israel Demonstrators in Colorado, 6 Injured
By Joseph Lord The FBI has named the suspect in a violent attack in Boulder, Colorado, as 45-year-old Mohamed Sabry...
Taylor Swift Big Win, Claims Back Her Earliest Albums
Mega Pop Star, Taylor Swift has reached a significant milestone of her career as she has reacquired the master recordings...